ATE421530T1 - Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein - Google Patents

Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein

Info

Publication number
ATE421530T1
ATE421530T1 AT03749859T AT03749859T ATE421530T1 AT E421530 T1 ATE421530 T1 AT E421530T1 AT 03749859 T AT03749859 T AT 03749859T AT 03749859 T AT03749859 T AT 03749859T AT E421530 T1 ATE421530 T1 AT E421530T1
Authority
AT
Austria
Prior art keywords
peptide
hiv
branches
rqgys
rqgy
Prior art date
Application number
AT03749859T
Other languages
English (en)
Inventor
Kamel Mabrouk
Jean-Marc Sabatier
Herve Rochat
Rietschoten Jurphaas Van
Original Assignee
Cellpep Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellpep Pharma Inc filed Critical Cellpep Pharma Inc
Application granted granted Critical
Publication of ATE421530T1 publication Critical patent/ATE421530T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03749859T 2002-04-19 2003-04-22 Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein ATE421530T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/126,915 US7285621B2 (en) 1999-06-29 2002-04-19 Multiple branch peptide construction

Publications (1)

Publication Number Publication Date
ATE421530T1 true ATE421530T1 (de) 2009-02-15

Family

ID=29418337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03749859T ATE421530T1 (de) 2002-04-19 2003-04-22 Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein

Country Status (7)

Country Link
US (1) US7285621B2 (de)
EP (1) EP1497323B1 (de)
AT (1) ATE421530T1 (de)
AU (1) AU2003242525A1 (de)
CA (1) CA2482690A1 (de)
DE (1) DE60325955D1 (de)
WO (1) WO2003095479A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004240765B2 (en) * 2003-05-20 2009-03-19 Cellpep Sa Modified antiviral peptides with increased activity and cell membrane affinity
EP1621203A1 (de) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibierende Peptide für die Behandlung von HIV-Infektion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318901D0 (en) * 1993-09-13 1993-10-27 Centre Nat Rech Scient Multiple branch peptide construction
GB9627114D0 (en) * 1996-12-31 1997-02-19 Centre Nat Rech Scient Multiple branch peptide constructions
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Also Published As

Publication number Publication date
US7285621B2 (en) 2007-10-23
EP1497323A1 (de) 2005-01-19
US20060155108A1 (en) 2006-07-13
CA2482690A1 (en) 2003-11-20
DE60325955D1 (de) 2009-03-12
WO2003095479A1 (en) 2003-11-20
EP1497323B1 (de) 2009-01-21
AU2003242525A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
CA2208420A1 (en) Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
CA2794632A1 (en) Bifunctional molecules for inactivating hiv and blocking hiv entry
AR029810A1 (es) Metodos y composiciones para la inhibicion de los acontecimientos asociados con la fusion de membrana, incluyendo la transmision de rsv
NO20014841D0 (no) Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet
BR9709524A (pt) Anticorpos contra um complexo de cd4 e um domìnio receptor de quimiocina e seu uso contra infecções de hiv
ES2137378T3 (es) Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.
ATE421530T1 (de) Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein
SE8701628D0 (sv) Medel for analys mm
AP9901615A0 (en) Multiple branch peptide constructions.
WO2004029201A3 (en) Peptide derivative fusion inhibitors of hiv infection
ATE491719T1 (de) Peptidinhibitoren gegen den eintritt von hiv in zellen
NAKASHIMA et al. FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2', 3'-dideoxynucleosides
WO2002064154A3 (en) Methods and compositions for inhibiting hiv-coreceptor interactions
WO2004016732A3 (en) Astrocyte modulated genes and uses thereof
AU2004240765B2 (en) Modified antiviral peptides with increased activity and cell membrane affinity
CA2171531A1 (en) Multiple branch peptide constructions for use against hiv
WO2004029074A3 (en) Hiv-derived hr1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus
WO2006109174A3 (en) Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
PT99791B (pt) Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem
EA200401611A1 (ru) Пептиды gp41 и способы ингибирования слияния вич с клетками-мишенями на их основе
TH22767A (th) เพทไทด์ชนิดหลายแขนงที่สร้างขึ้นสำหรับใช้ต่อ hiv
DE60328491D1 (de) Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung
WO2022146154A3 (en) Peptide for use in the treatment or prevention of covid-19

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties